SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid a prolonged selloff and underperformance in Chinese internet stocks, with traders pointing to weak investor flows, economic and policy uncertainty, and pressure on major holdings. Some see oversold conditions and support as a potential rebound setup, while others view the persistent weakness as evidence that the sector remains a value trap.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas rally and new highs are being linked to its earnings beat and raised full-year outlook, alongside a reported KFC U.S. beverage partnership that would shift the chain from Pepsi to Coke. Traders are also treating KO as a defensive hold amid weakness in technology stocks, while some caution that the run has left the shares expensive or overbought.

Cash Cat

CASHCAT is drawing attention for sharp, speculative swings, with traders debating whether pullbacks are buying opportunities before another rally or signs of a pump-and-dump and fading momentum. Some point to its Robinhood-chain presence and speculate about token burns or a short squeeze, but no fresh, verified catalyst is established.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanleys quarterly earnings beat estimates, with strong equity trading and wealth-management results, but shares fell as traders questioned whether the beat was already priced in and weighed sequentially weaker trading activity, soft fixed income and higher costs. The reaction also reflected broader pressure on financial stocks amid hotter inflation data, with some investors viewing the pullback as a buying opportunity.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

A steep selloff in obesity-drug biotech shares has put GPCRs valuation and oral GLP-1 pipeline under scrutiny, with traders debating whether the decline reflects broader sector pressure or concerns about alenigliprons efficacy, tolerability and timeline to Phase 3 results. Some holders view the cash and pipeline as undervalued, while others remain cautious; buyout talk is speculation.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

A sharp LINK rebound and breakout attempts are driving attention, with traders pointing to Chainlinks institutional and tokenization integrationsand an AI-related launchas bullish context. Others question whether the rally can hold, citing past reversals, selling pressure, and uncertainty over whether network adoption translates into value for the LINK token.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

Discussion centers on lawsuits alleging brake-cylinder failures in several 2025 GM models and engine defects in some trucks and SUVs; the claims remain allegations, and no class has been certified. Some traders are wary of the legal and quality concerns, while others point to a recent share-price rebound and remain bullish.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights mainnet rollout and related validator and partnership updates are driving discussion, with traders weighing the projects privacy and adoption potential against concerns about Googles role, ongoing token distributions, and weak buying interest. Reactions are split between long-term optimism and doubts that the developments are translating into sustained demand for NIGHT.

WorldFinancial

Traders are focused on World Liberty Financials preliminary bank-charter approval for USD1, which bullish posters see as a potential catalyst for WLFI and future stablecoin utility. Others are skeptical, pointing to the tokens weak performance and concerns about Trump-family involvement, selling pressure, and whether the charter will translate into value for holders.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

LHXs rebound after a prolonged defense-sector selloff has traders debating whether oversold conditions and renewed sector buying signal stabilization or only a temporary bounce. Some also point to new propulsion and night-vision contracts as support for the companys defense-demand outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Attention centers on Alpha Taus clinical catalyst pipeline: the IMPACT pancreatic-cancer study completed enrollment after expanding from 12 to 48 patients, with data expected in late 2026 or early 2027, alongside anticipated glioblastoma and skin-cancer updates. Traders are mostly bullish and view the milestones as support for the stock, while some caution that early clinical signals and the recent run do not remove the risks or near-term volatility.

New Strong Sell Stocks for July 7th

AMPX, DRTS and BELFB have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2026.

New Strong Sell Stocks for July  2nd

DRTS, CANG and LAZ have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2026.

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic...

DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing

Equity

Alpha Tau signed an agreement with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.

DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week

An extract featuring safety and efficacy results from three studies evaluating its key therapy for pancreatic cancer will be unveiled on Thursday.

Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally

Alpha Tau Medical stock surged after interim glioblastoma data showed complete responses in two patients treated with Alpha DaRT.read more...

DRTS Stock Surges Pre-Market Even As Retail Traders Debate ‘Too Small’ Brain Cancer Trial Data 

The biotech company’s experimental treatment for recurrent glioblastoma resulted in complete responses in 2 of the first 3 patients.

Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 


DRTS Stock Rises Overnight: Early US Brain Cancer Trial Results Expected Today

Last week, Alpha Tau Medical completed enrollment in its ReStart study for recurring skin cancer.

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Still a Buy?

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's Why...

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

ALPHA TAU MEDICAL LTD

Alpha Taus completed enrollment in its expanded IMPACT pancreatic cancer study is drawing attention, alongside anticipated updates from its glioblastoma and skin-cancer programs. Traders view the pipeline milestones as potential catalysts, though some are debating what the trial expansion signals and pointing to recent price volatility.

Current Price	$12.29
Prev Close	$13.16
Open	$13.24
Dividend Yield	0.00%
50-Day Moving Average	$14.45
Beta	0.83
Avg. Volume	509,675.01
PE Ratio	-11.82

52-Week High	$15.79
52-Week Low	$3.43
Market Capitalization	$1.14B
EPS (Annual)	-$0.529
Price to Book	25.76
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

DRTS Fundamentals